GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
26 hedge funds and large institutions have $162M invested in GW Pharmaceuticals Plc American Depositary Shares in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
325% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 4
222% more capital invested
Capital invested by funds: $50.5M → $162M (+$112M)
100% more funds holding
Funds holding: 13 → 26 (+13)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.8M |
| 2 |
O
OrbiMed
New York
|
+$10.1M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$6.17M |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
+$3.77M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$2.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$5.7M |
| 2 |
VM
VHCP Management
New York
|
-$4.38M |
| 3 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
-$838K |
| 4 |
PCM
Prelude Capital Management
New York
|
-$191K |
| 5 |
AIG
American International Group
New York
|
-$93.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $1K | +$569 | +18 | New |
|
|
BC
27
Broadfin Capital
New York
| – | -$5.7M | -332,936 | Closed |
|
|
CA
28
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
| – | -$838K | -48,321 | Closed |
|
|
PCM
29
Prelude Capital Management
New York
| – | -$191K | -11,000 | Closed |
|
|
U
30
UBS
Zurich,
Switzerland
| – | -$4K | -204 | Closed |
|
GWPH Hedge Fund Activity: Q4 2013 in Review
26 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q4 2013, worth a combined $162M — up 222% from $50.5M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new GWPH positions and 4 closed out — a net gain of 13 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $13.8M. The largest seller was Broadfin Capital, exiting entirely with an estimated $5.7M sold.
- 26 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q4 2013, up from 13 in Q3 2013.
- Funds reported $162M of GW Pharmaceuticals Plc American Depositary Shares stock for Q4 2013, up 222% quarter-over-quarter.
- 17 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q4 2013 and 4 closed out, a net change of +13 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q4 2013 was Fidelity Investments, an estimated $13.8M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q4 2013 was Broadfin Capital, an estimated $5.7M sold.
Based on aggregated 13F filings for Q4 2013.